Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Tambovenergosbyt reported for 2023 by IFRS

3/22/24 TASB

VK consolidated 100% of the educational platform SkillFactory

3/22/24 VKCO

Court seized shares of Solikamsk Magnesium Plant from minority shareholders

3/22/24 MGNZ

Yandex expands the geography of presence of robot couriers

3/22/24 YNDX

Board of Directors of LUKOIL recommended that dividends be paid for 2023

3/22/24 LKOH

Phosagro launches a new horizon at Kirovsky mine

3/22/24 PHOR

VK acquires YClients platform for ₽3.9 billion

3/22/24 VKCO

Russian Post will issue orders from Yandex.Market throughout Russia

3/22/24 YNDX

X5 Retail Group reported for 2023

3/22/24 X5

Segezha will carry out additional capitalization

3/22/24 SGZH